Abstract Chimeric antigen receptor (CAR) NK and T cell therapy are promising immunotherapeutic approaches for the treatment of cancer. However. the efficacy of CAR NK/T cell therapy is often hindered by various factors. including the phenomenon of trogocytosis. https://www.roneverhart.com/HP-Victus-15L-TG02-0325m-Gaming-Desktop-AMD-Ryzen-7-5700G-3-8-GHz-Radeon-RX-6400-32GB-DDR4-1TB-SSD-Windows-11-Home-Mi/